Royalty Pharma plc (RPRX) Balance Sheet
As of 2026-06-30 (10-Q), Royalty Pharma plc (RPRX) reported total assets of $19.8B, total liabilities of $10.0B and shareholders' equity of $9.8B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $812.0M. Long-term debt: $8.6B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RPRXRoyalty Pharma plcFollow RPRX — free
—
Price chart with a free account
- Market cap
- 36.7B
- P/E TTM
- 34.0
- Dividend yield
- 1.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.01 | 1.54 | 1.71 | 0.48 | 0.93 | 0.62 | 0.81 | |
| Short-term investments | 0.07 | 0.07 | 0.00 | 0.02 | 0.06 | 0.02 | 0.03 | |
| Current assets | 2.70 | 2.88 | 2.55 | 1.27 | 1.80 | 1.53 | 1.76 | |
| Total assets | 16.02 | 17.52 | 16.81 | 16.38 | 18.22 | 19.62 | 19.82 | |
| Current liabilities | 0.31 | 0.17 | 1.17 | 0.16 | 1.25 | 0.64 | 0.63 | |
| Long-term debt | 5.82 | 7.10 | 6.12 | 6.14 | 6.61 | 8.57 | 8.58 | |
| Short-term debt | 0.00 | 0.00 | 1.00 | 0.00 | 1.00 | 0.38 | 0.38 | |
| Total liabilities | 6.12 | 7.27 | 7.29 | 6.30 | 7.88 | 9.91 | 10.03 | |
| Shareholders' equity | 9.90 | 10.25 | 9.53 | 10.08 | 10.34 | 9.71 | 9.79 |
USD billions · SEC XBRL
Royalty Pharma plc — questions
- How much cash does Royalty Pharma plc have?
- $812.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does Royalty Pharma plc have?
- $8.6B of long-term debt and $380.0M due within a year as of 2026-06-30.
- What are Royalty Pharma plc's total assets?
- $19.8B as of 2026-06-30.
- What is Royalty Pharma plc's shareholders' equity?
- $9.8B as of 2026-06-30.
Every figure on this page comes from Royalty Pharma plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.